Third Harmonic Bio (THRD) | Stock Overview & Key Data
Third Harmonic Bio Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $24.59 on October 31, 2022
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Third Harmonic Bio
THRD
|
242.79M Micro-cap | 0.00% | -1.28% | 4.47% | 56.40% | 56.40% | -53.82% | -70.11% | -70.11% | -70.11% | -70.11% | -70.11% |
|
Vertex
VRTX
|
109.45B Large-cap | -2.49% | -1.11% | -12.54% | -1.86% | -5.98% | 1.24% | 34.08% | 113.19% | 376.31% | 717.28% | 1,190.86% |
|
Regeneron
REGN
|
80.98B Large-cap | -5.03% | -15.02% | -23.79% | -18.77% | -22.36% | 25.39% | -16.92% | 20.10% | 53.41% | 959.24% | 4,557.42% |
|
Editas Medicine
EDIT
|
322.98M Small-cap | -8.44% | -6.00% | 31.16% | 33.65% | 37.56% | 101.16% | -64.22% | -89.72% | -89.74% | -80.34% | -80.34% |
| 370.31M Small-cap | -4.07% | -12.62% | 6.52% | 1.92% | 3.58% | 18.15% | 27.78% | -74.07% | -64.62% | -64.62% | -64.62% | |
|
Alector
ALEC
|
265.97M Small-cap | -10.96% | -22.31% | -11.76% | 71.05% | 27.45% | 62.41% | -69.66% | -88.95% | -86.75% | -86.75% | -86.75% |
Ownership & Short Interest
Calculate Your Third Harmonic Bio Investment Returns
Long-Term Investment Performance Analysis
Third Harmonic Bio stock price in Sep 2022 was $18.00, A $1,000.00 lump sum investment in Third Harmonic Bio made 2 years ago would be worth approximately $298.89 today, representing a negative return of -70.11%. This translates to an annualized return (CAGR) of -33.89%.
2 Years 11 Months Investment Scenario (Sep 2022 - Aug 2025)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is THRD's 52-week high and low?
- In the last 52 weeks, Third Harmonic Bio reached a high of $16.02 (on September 20, 2024) and a low of $3.18 (on February 11, 2025).
- What is the market cap and P/E ratio for THRD?
- Curious about Third Harmonic Bio's size and valuation? Its market capitalization stands at 242.79M. When it comes to valuation, the P/E ratio (trailing twelve months) is 12.46, and the forward P/E (looking ahead) is -3.49.
- Does THRD pay dividends? If so, what's the yield?
- As for dividends, Third Harmonic Bio isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Third Harmonic Bio's main competitors or similar companies to consider before investing?
When looking at Third Harmonic Bio, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Vertex
VRTX109.45B Healthcare Biotechnology 1.24% 34.08% Regeneron
REGN80.98B Healthcare Biotechnology 25.39% -16.92% Editas Medicine
EDIT322.98M Healthcare Biotechnology 101.16% -64.22% Silence Therapeutics
SLN370.31M Healthcare Biotechnology 18.15% 27.78% Alector
ALEC265.97M Healthcare Biotechnology 62.41% -69.66% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Third Harmonic Bio, Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Third Harmonic Bio's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -19.94%, the Debt to Equity ratio from the most recent quarter is 1.10, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for THRD?
- Looking at Third Harmonic Bio's growth, its revenue over the trailing twelve months (TTM) was $0. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of THRD stock is held by insiders and institutions?
- Wondering who owns Third Harmonic Bio stock? Company insiders (like executives and directors) hold about 9.11% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 80.12%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.